We are live on ! Find out more
PTJ

Paul Tudor Jones Tudor Investment Corp

AUM $71.9B
1-Year Est. Return 42.37%
 

Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.

This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+42.37%
3 Year Est. Return
+108.76%
5 Year Est. Return
+114.43%
10 Year Est. Return
+640.77%
AUM
$2.87B
AUM Growth
-$216M
Cap. Flow
-$317M
Cap. Flow %
-11.04%
Top 10 Hldgs %
41.01%
Holding
1,369
New
402
Increased
318
Reduced
264
Closed
354

Sector Composition

Rank Sector Weight
1 Technology 10.89%
2 Consumer Discretionary 10.62%
3 Financials 10.25%
4 Healthcare 8.72%
5 Industrials 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGTC
1001
DELISTED
Applied Genetic Technologies Corporation
AGTC
$55K ﹤0.01%
14,839
FRED
1002
DELISTED
Fred's Inc
FRED
$52K ﹤0.01%
22,969
-20,342
-47% -$44.3K
PETX
1003
DELISTED
Aratana Therapeutics, Inc.
PETX
$44K ﹤0.01%
+10,463
New +$52.8K
AGEN
1004
Agenus
AGEN
$364M
$43K ﹤0.01%
+971
New +$65.4K
GTYHW
1005
CALL
DELISTED
GTY Technology Holdings, Inc. Warrants
GTYHW
$42K ﹤0.01%
33,332
KGC icon
1006
Kinross Gold
KGC
$38.9B
$41K ﹤0.01%
10,893
-2,007
-16% -$7.54K
KERX
1007
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$41K ﹤0.01%
+10,980
New +$53.5K
MN
1008
DELISTED
MANNING & NAPIER, INC.
MN
$38K ﹤0.01%
12,147
ARC
1009
DELISTED
ARC Document Solutions, Inc.
ARC
$38K ﹤0.01%
21,551
CLDX icon
1010
Celldex Therapeutics
CLDX
$3.17B
$33K ﹤0.01%
4,363
-1,404
-24% -$18.8K
ARAV
1011
DELISTED
Aravive, Inc. Common Stock
ARAV
$26K ﹤0.01%
2,128
SQBG
1012
DELISTED
Sequential Brands Group, Inc.
SQBG
$26K ﹤0.01%
332
NVAX icon
1013
Novavax
NVAX
$1.47B
$23K ﹤0.01%
+869
New +$29.4K
NAVB
1014
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$11K ﹤0.01%
2,327
RAS
1015
DELISTED
RAIT Financial Trust
RAS
$6K ﹤0.01%
66,662
AAOI icon
1016
Applied Optoelectronics
AAOI
$10.6B
-9,753
Closed -$244K
ACIW icon
1017
ACI Worldwide
ACIW
$5.24B
-28,481
Closed -$676K
ACN icon
1018
Accenture
ACN
$113B
-4,924
Closed -$756K
AEE icon
1019
Ameren
AEE
$29.4B
-19,110
Closed -$1.08M
AEP icon
1020
American Electric Power
AEP
$65.8B
-4,658
Closed -$319K
AGCO icon
1021
AGCO
AGCO
$7.48B
-18,317
Closed -$1.19M
AIG icon
1022
American International
AIG
$39.8B
-71,319
Closed -$3.88M
AIZ icon
1023
Assurant
AIZ
$14B
-9,879
Closed -$903K
AKBA icon
1024
Akebia Therapeutics
AKBA
$251M
-21,105
Closed -$201K
ALKS icon
1025
Alkermes
ALKS
$8.11B
-15,666
Closed -$908K

Similar funds

Paul Tudor Jones's Q2 2018 Portfolio in Review

As of Q2 2018, Paul Tudor Jones held 1,369 positions worth $2.87B, down 7% from $3.09B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Paul Tudor Jones withdrew a net $317M in Q2 2018, closing 354 positions and reducing 264 holdings. Its most notable exit was CSRA Inc., an estimated $37.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Paul Tudor Jones opened a new position in Home Depot worth $21.3M.

  • Paul Tudor Jones's largest Q2 2018 buy was Home Depot: 109,196 shares worth $21.3M.
  • Paul Tudor Jones added most to Pinnacle Foods, Inc. in Q2 2018, an estimated $48.4M increase.
  • Paul Tudor Jones's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $501M.
  • Paul Tudor Jones fully exited CSRA Inc. in Q2 2018, selling an estimated $37.1M.
  • Paul Tudor Jones's ten largest holdings make up 41% of its $2.87B portfolio in Q2 2018.
  • Paul Tudor Jones opened 402 new positions and closed 354 in Q2 2018.
  • Paul Tudor Jones's portfolio value fell 7% quarter-over-quarter to $2.87B.

Based on Tudor Investment Corp's 13F filing for Q2 2018, filed 14 Aug 2018.